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Abstract: On a global research expedition, over 500 bacterial strains inhibitory towards 
pathogenic bacteria were isolated. Three hundred of the antibacterial strains were assigned 
to the Vibrionaceae family. The purpose of the present study was to investigate the 
phylogeny and bioactivity of five Vibrionaceae strains with pronounced antibacterial 
activity. These were identified as Vibrio coralliilyticus (two strains), V. neptunius 
(two strains), and Photobacterium halotolerans (one strain) on the basis of housekeeping 
gene sequences. The two related V. coralliilyticus and V. neptunius strains were isolated 
from distant oceanic regions. Chemotyping by LC-UV/MS underlined genetic relationships 
by showing highly similar metabolite profiles for each of the two V. coralliilyticus and 
V. neptunius strains, respectively, but a unique profile for P. halotolerans. Bioassay-guided 
fractionation identified two known antibiotics as being responsible for the antibacterial 
activity; andrimid (from V. coralliilyticus) and holomycin (from P. halotolerans). Despite 
the isolation of already known antibiotics, our findings show that marine Vibrionaceae are 
a resource of antibacterial compounds and may have potential for future natural 
product discovery.  
OPEN ACCESS 
Mar. Drugs 2010, 8  
 
 
2947 
Keywords: Vibrio coralliilyticus; Vibrio neptunius; Photobacterium halotolerans; 
chemotyping; andrimid; holomycin  
 
1. Introduction  
Bioactive secondary metabolites are believed to play a key role in microbial interactions by 
mediating antagonistic activity and intercellular communication [1]. In addition, many microbial 
natural products have biotechnological potential as antibiotics, biosurfactants, antifungal, or anticancer 
agents [2]. Sequences of microbial genomes revealed that only a small fraction of the natural product 
diversity is known, highlighting the potential for finding novel bioactive compounds in environmental 
microorganisms [3]. The need for novel antimicrobials to combat increasing antibiotic resistances in 
pathogenic bacteria has stimulated the exploration of other than the traditional sources, such as 
terrestrial actinomycetes or fungi [4]. 
The marine environment harbors bacteria with antagonistic traits [5,6], and marine microorganisms 
are a potential source of novel antimicrobials [7]. Antagonistic marine bacteria have been isolated from 
surface [8] and deep waters [9], but the majority originated from biotic surfaces such as sponges [10], 
zooplankton and macroalgae [8,11], corals [12], and bryozoans [13]. Bioactive bacterial strains 
predominantly belong to Pseudoalteromonas spp. [14], the Roseobacter clade [15], and 
Actinobacteria [16]. A number of marine-derived antimicrobials have been characterized in greater 
detail, including halogenated [17] and sulfuric [18] compounds, depsipeptides [19] and lipopeptides [20], 
glycolipids [21], as well as high molecular weight structures such as amino acid oxidases [22]. 
Also the Vibrionaceae family, Gram-negative Gammaproteobacteria ubiquitous in marine and 
brackish environments [23], harbors strains with antagonistic activity [8]. The family comprises eight 
genera, with Vibrio and Photobacterium constituting the majority of species. To date, Vibrionaceae 
have primarily been investigated due to their pathogenic potential to humans and aquatic animals, but 
they also occur in commensal or symbiotic associations with eukaryotic organisms [23]. While the 
abundance of Vibrionaceae in nutrient-rich microenvironments such as chitinous zooplankton is 
potentially related to a superior nutrient utilization based on their metabolic versatility [24], 
antagonism of competing bacteria through production of antimicrobial compounds may also contribute 
to a selective advantage. Antimicrobials from Vibrio spp. can reduce the number of other microbial 
community members and influence microscale variations in competing bacterial populations [6]. 
Antibacterial activities have been described from V. alginolyticus [25], V. parahaemolyticus [26], 
V. anguillarum [27], and several unidentified Vibrio spp. [28,29]. However, the nature and frequency 
of antagonism among vibrios is still largely unknown, and only a few antibiotic Vibrio compounds 
have been structure elucidated to date [30,31]. 
The present study describes the analysis of bioactive Vibrionaceae strains collected during a global 
marine expedition [8]. The purpose was to (i) provide phylogenetic and chemical analyses of the 
strains with strongest antibacterial activity; (ii) characterize their bioactivity depending on culture 
conditions; and (iii) isolate and elucidate the structure of bioactive metabolites. We report the 
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identification of five Vibrionaceae strains with pronounced antibacterial activity, the use of 
chemotyping to support genetic identification, and the structures of two antibacterial compounds.  
2. Results and Discussion 
2.1. Selection of Strains with Pronounced Antibacterial Activity 
Three hundred and one Vibrionaceae strains were isolated during a global marine expedition 
(http://www.galathea3.dk/uk) based on their ability to antagonize the fish pathogen Vibrio anguillarum 
strain 90-11-287 [8]. After being stored at −80 °C for between six and 12 months, all strains were 
retested for antibacterial activity against V. anguillarum strain 90-11-287 and the human pathogen 
Staphylococcus aureus strain 8325 by spotting colony mass on pathogen-seeded agar [8]. Activity was 
assessed by the formation of clearing zones around spotted colony mass. From 301 strains, only 
138 retained antibacterial activity, being a small fraction compared to other antagonistic marine 
bacteria [32,33]. One hundred strains causing pronounced inhibition (diameter of clearing zones larger 
than 10 mm) were retested using the same set-up, resulting in a subselection of 39 strains with 
reproducible strong antibacterial activity when spotted on pathogen-seeded agar. This subselection was 
inoculated in liquid cultures and extracted with ethyl acetate to determine if antibacterial compounds 
were extractable with organic solvent. Activity was seen in ethyl acetate extracts from five strains, 
which were selected for further analyses. The five bioactive strains originated from different surface 
samples collected in distant oceanic regions (Figure 1).  
Figure 1. Site of isolation, source, and species identification of five bioactive marine 
Vibrionaceae. Strains were identified to the species level by sequence analysis of several 
housekeeping genes (see below).  
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2.2. Phylogenetic Identification and Chemotyping of Strains 
All strains investigated in the present study had previously been assigned to the Vibrionaceae 
family based on 16S rRNA gene similarities [8]. However, the 16S rRNA gene is highly conserved 
among the Vibrionaceae and is not well suited for identification to the species level [34]. Therefore, 
additional sequence analyses of three housekeeping genes (recA, rpoA, and toxR) were performed. 
These genes encode constitutively expressed proteins and are suitable for phylogenetic studies of 
Vibrionaceae [34,35]. On the basis of recA and rpoA sequence similarities, strains S2052 and S4053 
were identified as Vibrio coralliilyticus, S2394 and S4051 as Vibrio neptunius, and S2753 as 
Photobacterium halotolerans (Figure 1). The toxR gene was less suited for general species 
identification due to its high variability even in closely related vibrios, as well as comparatively few 
toxR sequence data available in public gene libraries [36]. However, multiple alignments and  
neighbor-joining analyses of toxR sequences provided the best phylogenetic resolution for determining 
the relationship between the five strains (Figure 2). The usefulness of toxR for species discrimination 
was consistent with previous reports [35]. LC-UV/MS metabolite profiles underlined the close 
relationship between V. coralliilyticus S2052/4053 and V. neptunius S2394/4051, respectively. The 
evolutionary distance of P. halotolerans S2753 to the other strains was reflected by a unique 
metabolite profile (Figure 2). All five strains were consistent in their metabolite production in separate 
cultivations over a one-year interval.  
Several metabolites were produced by all V. coralliilyticus and V. neptunius strains, for instance 
those related to the peaks at retention times Rt = 11.08 and 12.03 min (Figure 2). Although they are 
different species, V. coralliilyticus and V. neptunius are closely related vibrios with only 2–3% 
sequence variation in the recA and rpoA genes (data not shown), signifying why biosynthetic pathways 
are shared between the species. Based on their molecular formulas, UV, and MS characteristics [37], 
most of the metabolites produced by both species were assigned as smaller peptides (m/z 300–500), a 
class of molecules commonly produced by marine culturable bacteria [38,39]. Despite the presence of 
shared metabolites between V. coralliilyticus and V. neptunius, clearly distinguishable peaks were seen 
as well. For instance, the major peak at retention time Rt = 10.02 min (MW 479 Da) was only seen in the 
two V. coralliilyticus, and the peak at Rt = 10.11 min (MW 493 Da) only in the two V. neptunius strains.  
The metabolites produced by P. halotolerans S2753 comprised a series of larger peptides  
(m/z 500–900) [40]. The large peak at Rt = 1.70 min (MW 213 Da) displayed a unique UV spectrum 
characteristic of that of a highly conjugated system. However, this peak could not be ascribed to any 
known compound or compound class based on LC-UV/MS data alone.  
Several metabolites (Rt = 4.70, 7.41, 8.60, 9.60, and 10.50 min) were found in all five strains and 
assigned as poly-β-hydroxybutyric acid polymers (PHB) of varying lengths (repeating unit n = 86 Da). 
This was verified by NMR for some of the compounds (data not shown). PHB are common bacterial 
storage compounds accumulated when growing on an excess carbon source [41]. 
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Figure 2. Phylogenetic and chemical relationship between five bioactive Vibrionaceae 
based on neighbor-joining analyses of aligned toxR gene sequences and LC-MS Total Ion 
Chromatograms (TIC). The scale bar relates to the number of base substitutions in toxR 
gene sequences (as displayed by branch lengths in the phylogenetic tree). 
 
V. neptunius
V. coralliilyticus
P. halotolerans
0.05
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
S4053
S2052
10.02
8.77
7.12
11.08
12.03
12.95
10.02
8.77
7.12
11.08
12.03
12.95
5.91
18.64
Time
2.00 4.00 . . . .
%
0
100
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
S4051
S2394
11.08
11.56
10.11
9.62
8.777.12
7.43
8.60
13.4012.40
7.43
8.60
9.62 10.11
11.08
11.56
13.4012.40
3.67
9.72
3.67
Time
2.00 4.00 . . . .
%
0
100
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100 14.75
15.34
16.05 16.95
18.55
13.70
13.25
S2753
1.70
Time
2.00 4.00 . . . .
%
0
100
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
%
0
100
Mar. Drugs 2010, 8  
 
 
2951 
Chemotyping of prokaryotes has mostly been restricted to analyses of fatty acids and sugars [42], 
but we show that also the profiling of small molecules can be used for species discrimination. This 
highlights the usefulness of metabolomics for bacterial classification, adding to recent work of 
whole-cell laser desorption MALDI-TOF mass spectrometry for characterization of vibrios [43] and 
secondary metabolite profiling to assess the biosynthetic potential of marine Pseudoalteromonas [32]. 
While our study is limited to the analysis of only three species from the Vibrionaceae family, the 
isolation of two genetically and chemically closely related “strain siblings” from distant oceanic 
regions indicated that production of certain secondary metabolites is a preserved trait. Similar 
secondary metabolite profiles were also shown for marine actinomycetal Salinispora spp. [44] from 
distant habitats. Also, all Ruegeria mobilis strains from worldwide locations produced the same 
antibiotic, tropodithietic acid [33]. 
2.3. Bioassay-Guided Identification of Antibacterial Compounds 
V. coralliilyticus (strains S2052 and S4053) and P. halotolerans (S2753) inhibited both 
V. anguillarum and S. aureus, whereas V. neptunius (strains S2394 and S4051) only inhibited 
V. anguillarum (Table 1). Antibacterial activity was highest in aerated cultures and detected after one, 
three, and five days of incubation. No significant difference in activity was seen between the tested 
culture media. 
Table 1. Inhibition of V. anguillarum strain 90-11-287 and S. aureus strain 8325 by ethyl 
acetate extracts from five marine Vibrionaceae. Antibacterial activity is displayed by the 
diameter of clearing zones (−: no activity; +: between 0 and 15 mm; ++: between 15 and 
30 mm; +++: over 30 mm). 
  Inhibition of  
Strain Species V. anguillarum S. aureus 
S2052 V. coralliilyticus +++ ++ 
S2394 V. neptunius ++ − 
S2753 P. halotolerans +++ ++ 
S4051 V. neptunius ++ − 
S4053 V. coralliilyticus ++ + 
The finding of bioactivity among marine Vibrionaceae underlined marine microorganisms being a 
source of antimicrobials. To our knowledge, none of the species investigated here have previously 
been studied with respect to their secondary metabolome including antibacterial compounds.  
To identify the compounds responsible for the observed activity, large-scale cultivations and 
fractionations were undertaken for V. coralliilyticus S2052 and P. halotolerans S2753, representing 
two distant Vibrionaceae species with different metabolite profiles. All fractionation steps were guided 
by activity testing against V. anguillarum strain 90-11-287. 
Initial dereplication of S2052 by LC-UV/MS [37] and explorative solid-phase extraction (E-SPE) [45] 
indicated that andrimid (Rt = 10.02 min; Figure 2) could be responsible for the antibacterial activity. 
This compound (Figure 3a), a hybrid nonribosomal peptide-polyketide antibiotic, was first described 
from an insect endosymbiont [46] and later found in other microbial species [47,48] including marine 
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vibrios [29,31]. Pure andrimid was isolated for NMR analysis, and our data was in accordance with 
literature data [47]. Andrimid acts as an acetyl-CoA carboxylase inhibitor [49], and we extended its 
broad antibiotic spectrum [50] by showing inhibition of the bacterial pathogens Salmonella Enteritidis, 
Bacillus cereus, Yersinia enterolitica, Yersinia ruckeri, Vibrio harveyi, and Vibrio vulnificus (data not 
shown). Production of andrimid was also confirmed for the other isolated V. coralliilyticus strain, 
S4053. We furthermore speculate whether a recent report of antagonism in the V. coralliilyticus type 
strain [12] was also attributed to this compound. Previous studies have revealed almost identical 
andrimid gene clusters and a transposase pseudogene in two producer species, suggesting horizontal 
gene transfer as the most likely explanation behind the cosmopolitanism of the antibiotic [51]. We 
hypothesize that such transfer is also the reason for its presence in V. coralliilyticus S2052 and S4053. 
Our study is the first linking andrimid production to a specific Vibrio species, with production 
occurring in two strains isolated from very different geographical regions and sources.  
The antibacterial compound of P. halotolerans S2753 was identified as holomycin (Rt = 1.70 min; 
Figure 2), a compound belonging to the pyrrothine class of antibiotics acting by interference with RNA 
synthesis [52]. Our NMR data (Figure 3b) was consistent with previous reports [53]. Holomycin has 
until now only been found in Gram-positive Streptomyces [54,55], and the present study is the first 
demonstrating production of this antibiotic in a Gram-negative heterotrophic bacterium. While parallel 
evolution of this trait is possible, horizontal gene transfer is the more likely explanation for its 
occurrence in both Vibrionaceae and actinomycetes. We extended the broad-spectrum activity of 
holomycin [52] by showing inhibition of the bacterial pathogens Listeria monocytogenes, 
Serratia marcescens, S. Enteritidis, B. cereus, Y. enterolitica, Y. ruckeri, V. harveyi, V. vulnificus and 
V. parahaemolyticus, as well as of several marine strains from the Roseobacter and 
Pseudoalteromonas groups (data not shown). 
Figure 3. Structures of andrimid (a) and holomycin (b) isolated from marine Vibrionaceae. 
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dual physiology, being antagonistic against other prokaryotes but pathogenic towards higher 
organisms. Moreover, the production of antibiotics in several species suggests that these compounds 
may be of ecological importance [1]. 
This study highlights one of the challenges in natural product discovery. Despite major screening 
efforts for novel antimicrobials to be used in pharmaceutical, food, and aquaculture industries, only a 
limited amount of compounds have been discovered in recent years [58]. While the isolation of 
culturable bacteria remains a promising approach [42] and the secondary metabolome of marine 
vibrios has not been extensively studied, we only isolated known compounds despite careful 
dereplication prior to any compound purification. Dereplication is apparently troubled by the high 
degree of gene transfer between distantly related bacteria such as Gram-positive actinomycetes and 
Gram-negative Proteobacteria [3]. Many compounds in natural product databases such as AntiBase [59] 
have similar masses (<5 ppm difference), so even the combination of UV/VIS spectra, accurate mass 
data (<5 ppm), and E-SPE [45] is not sufficiently discriminatory for these organisms. To avoid 
isolation of redundant chemistry, dereplication by NMR [60] or ultra high-resolution mass 
spectrometry (<1 ppm) with high isotope accuracy ratios for correct elementary composition 
determination [61] is imperative to exclude previously isolated compounds.  
3. Experimental Section  
3.1. Isolation of Bioactive Marine Vibrionaceae 
During a global research expedition (http://www.galathea3.dk/uk), marine bacterial strains were 
isolated from environmental samples and screened for antagonistic activity against a pathogenic 
Vibrio anguillarum, strain 90-11-287. Three hundred and one bioactive strains were identified as 
Vibrionaceae based on 16S rRNA gene similarities [8]. Pure cultures of strains were stored in 
cryoprotectant solution at −80 °C until being analyzed in the present study. 
3.2. Selection of Strains with Pronounced Antibacterial Activity 
All 301 strains were retested for antibacterial activity by spotting colony mass on agar seeded with 
either V. anguillarum strain 90-11-287 or S. aureus strain 8325. Activity was assessed by the 
formation of clearing zones around spotted colony mass. Selected active strains were grown both 
stagnant and aerated (200 rpm) in 30 mL Marine Broth 2216 (Difco 279110) for 3 days at 25 °C in 
250 mL glass bottles. Cultures were extracted with an equal volume of HPLC-grade ethyl acetate 
(EtOAc) for 30 min. The organic phase was transferred to fresh sample vials and evaporated under 
nitrogen until dryness. Extracts were redissolved in 1 mL of EtOAc and stored at −20 °C until further 
analysis. EtOAc extracts were tested in a well diffusion agar assay [62] for activity against 
V. anguillarum strain 90-11-287 and S. aureus strain 8325.  
3.3. Phylogenetic Analysis 
Genomic DNA was extracted from 1-day cultures using the NucleoSpin Tissue Kit (Macherey-Nagel, 
Düren, Germany) according to the manufacturer's instructions. PCR for recA and toxR gene fragments 
was performed according to [35], and PCR for rpoA gene fragments according to [34]. PCR products 
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were checked by agarose gel electrophoresis and purified using the Wizard PCR Preps DNA Direct 
Purification System (Promega, Madison, USA) according to the manufacturer’s instructions. Obtained 
nucleotide sequences were edited using Chromas Lite (Technelysium, Australia) and aligned to its 
closest sequence relative [36]. The phylogenetic relationship between the five isolates was determined 
by neighbor-joining analyses (1000 bootstrap replicates) of nucleotide and amino acid alignments 
(translated using EMBOSS Transeq, http://www.ebi.ac.uk/Tools/emboss/transeq/) done in ClustalX. 
Gene sequences have been deposited at GenBank under the accession numbers HQ452614–452618 
(toxR), HQ452619–452623 (recA), and HQ452624–452628 (rpoA). 
3.4. Influence of Culture Conditions on Bioactivity 
The five strains with strongest antibacterial activity (S2052, S2394, S2753, S4051, and S4053) were 
grown both stagnant and aerated (200 rpm) at 25 °C in either Marine Broth (MB) or Marine Minimal 
Medium [63] containing 0.4% glucose and 0.3% casamino acids (MMM). Per strain and culture 
condition, three bottles were inoculated with 30 mL of medium each, of which each one was sampled 
after 1, 3, and 5 days of incubation. In addition, strains were grown in 30 mL sea salt solution (Sigma 
S9883; 40 g L
−1
) with 0.4% glucose and 0.3% casamino acids for 3 days (200 rpm) at 25 °C. EtOAc 
extracts were prepared as described above, and tested in a well diffusion agar assay [62] for activity 
against V. anguillarum strain 90-11-287 and S. aureus strain 8325. 
3.5. Chemotyping 
Liquid chromatography-diode array/mass spectrometry (LC-UV/MS) analyses were performed on 
dried EtOAc extracts redissolved in methanol (MeOH) from all tested culture conditions to visualize 
the array of produced molecules. In addition, 3-day MMM cultures were extracted and analyzed in 
biological triplicate. LC-UV/MS was performed on an Agilent 1100 liquid chromatograph with a diode 
array detector (Agilent, Waldbronn, Germany) coupled to an LCT TOF mass spectrometer 
(Micromass, Manchester, UK) using a Z-spray ESI source. The separation was done on a Luna II C18 
column (50 mm × 2 mm, 3 µm) (Phenomenex, Torrance, CA) fitted with a security guard system using 
a linear gradient starting from 15% acetonitrile (MeCN) in water (H2O) to 100% MeCN over 20 min at 
a flow rate of 300 µL min
−1
. Both MeCN (HPLC grade) and H2O were buffered with 20 mM 
HPLC-grade formic acid (FA). 
3.6. Isolation and Structural Elucidation of Antibacterial Compounds 
Strains S2052 and S2753 were grown in 20 L sea salt solution (Sigma S9883; 40 g L
−1
) with 
0.4% glucose and 0.3% casamino acids for 3 days (100 rpm) at 25 °C. On day 3, sterile Dianion 
HP20SS resin (Sigma-Aldrich, St. Louis, MO) was added to the broth (12 g of resin L
−1
). After 24 h, 
the resin was filtered off and washed with H2O (2 × 1 L), followed by extraction with MeCN/H2O 
(80/20 v/v; 2 × 1500 mL).  
For S2052, all organic extracts were pooled, absorbed onto 90 g Sepra ZT C18 (Phenomenex), and 
dried before packing into a 100 g SNAP column (Biotage, Uppsala, Sweden) with pure resin (10 g) in 
the base. Using an Isolera flash purification system (Biotage), the extract was subjected to a crude 
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fractionation using a MeCN/H2O gradient (flow rate 30 mL min
−1
) starting with 10% MeCN (10 min, 
isocratic), increasing to 100% MeCN (25 min) before washing with 100% MeCN (15 min). Fractions 
were automatically collected using UV detection (210 and 320 nm). The fraction with antibacterial 
activity (185 mg) was subjected to further purification on a Luna II C18 column (250 × 10 mm, 5 μm) 
(Phenomenex) using a 45–70% MeCN/H2O gradient (buffered with 20 mM FA, flow rate 5 mL min
−1
) 
over 20 minutes on a Gilson 322 liquid chromatograph with a 215 liquid handler/injector (BioLab, 
Risskov, Denmark). This yielded 7.6 mg of pure andrimid.  
For S2753, the MeCN/H2O extract from Dianion HP20SS extraction was evaporated until dryness 
on a rotary evaporator. The extract was redissolved in EtOAc, absorbed onto 5 g Isolute diol (Biotage), 
and added to a glass column with pure diol (95 g). A total of 12 fractions were collected from the diol 
column (100 g, 20 × 350 mm) ranging from heptane, dichloromethane, EtOAc to pure MeOH, running 
under gravity. The fraction with antibacterial activity (172 mg, 100% EtOAc) was further separated on 
the Isolera flash purification system, on Sepra ZT C18 (10 g SNAP) using a MeCN/H2O gradient (flow 
rate 12 mL min
−1
) starting with 5% MeCN increasing to 30% MeCN (12 min), quickly increasing to 
100% MeCN (10 min). Fractions were automatically collected using UV detection (210 and 380 nm). 
Pure holomycin (4.3 mg) was obtained after final purification on a Luna II C18 column (250 × 10 mm, 
5 μm) (Phenomenex) using a MeCN/H2O (buffered with 20 mM FA) gradient from 7–37% MeCN 
over 17 min.  
NMR spectra were recorded on a Bruker Avance 800 MHz spectrometer with a 5 mm TCI 
Cryoprobe at the Danish Instrument Center for NMR Spectroscopy of Biological Macromolecules, 
using standard pulse sequences. The NMR data used for the structural assignment of andrimid and 
holomycin were acquired in DMSO-d6 (δH 2.49 and δC 39.5 ppm). 
Optical rotation was measured on a Perkin Elmer Model 341 polarimeter (Perkin Elmer, Waltham, 
MA) (αD at 589 nm). 
Andrimid: orange-yellow amorphous solid; UV (MeCN/H2O) λmax 200 (100%), 280 (40%) nm; 
[α]D
20
 −62.9° (c 0.24, MeOH); 1H NMR δH ppm: 0.75 (3H, d, 6.7 Hz, H-4’), 0.80 (3H, d, 6.7 Hz, H-5’), 
1.07 (d, 7.2 Hz, 1H, H-6), 1.78 (3H, d, 6.7 Hz, H-8’’’), 2.30 (m, 1H, H-3’), 2.65 (1H, dd, 14.6, 6.2 Hz, 
H-2a’’), 2.77 (1H, dd, 14.6, 8.2 Hz, H-2b’’), 2.91 (m, 1H, H-4), 3.92 (d, 5.6 Hz, 1H, H-3), 4.62 (dd, 8.4, 
5.4 Hz, 1H, H-2’), 5.28 (1H, m, H-3’’), 5.90 (1H, m, H-7’’’), 6.01 (1H, d, 15.2 Hz, H-2’’’), 6.18 (1H, m, 
H-6’’’), 6.26 (1H, dd, 14.5, 11.4 Hz, H-4’’’), 6.53 (1H, dd, 14.5, 10.0 Hz, H-5’’’), 7.00 (1H, dd, 15.2, 
11.4 Hz, H-3’’’), 7.20 (1H, m, H-7’’), 7.29-7.31 (4H, m, H-5’’/H-6’’), 8.11 (1H, d, 8.4 Hz, NH-2’), 
8.42 (1H, d, 8.5 Hz, NH-3’’), 11.36 ( s, 1H, NH-1); 13C NMR δC ppm: 14.5 (C-6), 17.2 (C-4’),  
18.3 (C-8’’’), 19.4 (C-5’), 28.1 (C-3’), 39.0 (C-4), 41.9 (C-2’’), 57.8 (C-3), 63.1 (C-2’), 124.2 (C-2’’’), 
126.4 (C-5’’), 126.9 (C-7’’), 128.1 (C-4’’’), 128.2 (C-6’’), 131.5 (C-6’’’), 133.4 (C-7’’’), 139.0 (C-5’’’), 
139.4 (C-3’’’), 142.9 (C-4’’), 164.3 (C-1’’’), 169.9 (C-1’’), 173.8 (C-2), 180.0 (C-5), 203.9 (C-1’); 
HRESIMS m/z 479.2435 (calcd for C27H33N3O5, 479.2420). 
Holomycin: orange-yellow prisms; UV (MeCN/H2O) λmax 200 (100%), 280 (40%) nm; 
1
H NMR 
δH ppm: 2.01 (s, 1H, H-9), 7.04 (s, 1H, H-1), 9.86 (s, 1H, NH-7), 10.69 (s, 1H, NH-3); 
13
C NMR 
δC ppm: 22.4 (C9), 110.6 (C-1), 115.4 (C-5), 133.7 (C-2), 133.9 (C-6), 167.9 (C-4), 168.8 (C-8); 
HRESIMS m/z 213.9860 (calcd for C7H6N2O2S2, 213.9871). 
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4. Conclusions 
The present study adds to the knowledge of Vibrionaceae bioactivity and physiology by showing a 
worldwide occurrence of marine strains producing antibacterial compounds. In addition, we underlined 
that chemotyping can support gene-based species identification and help resolving phylogenetic 
relationships within a genetically homogenous family such as the Vibrionaceae. The discovery of 
known antibiotics that are also produced by evolutionary distant microbes suggests an involvement of 
horizontal gene transfer, and indicates that these compounds are fundamental to compete and 
communicate in the natural habitat. The cosmopolitanism of identical antibiotics has major 
implications for natural product discovery strategies and stresses the need for careful dereplication in 
the initial stages of screening. An alternative approach could be the screening for largely untested 
bioactivities, for instance, interference with quorum sensing or modulation of gene expression. 
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